Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B

Author(s):

Josef Wagner, Lilly Yuen, Margaret Littlejohn, Vitina Sozzi, Kathy Jackson, Ross Martin, Thomas Aeschbacher, Vithika Suri, Susanna K. Tan, Becket Feierbach, Anuj Gaggar, Patrick Marcellin, Maria Buti Ferret, Harry L.A. Janssen, Ed Gane, Niamh Meagher, David J. Price, Darren Wong, Alexander T. Thompson, Peter A. Revill

Details:

Alimentary Pharmacology and Therapeutics, Volume 57, Issue 5, 2023-03-01

Article Link: Click here

Affiliations:

• The Peter Doherty Institute for Infection and Immunity
• Melbourne School of Population and Global Health
• Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
• University of Melbourne
• Toronto General Hospital
• Auckland City Hospital
• Hôpital Beaujon
• Royal Melbourne Hospital
• Gilead Sciences Incorporated
• St. Vincent's Hospital Melbourne